Spine Deal Redux: Alphatec Makes Another Go At Acquiring Scient'x
This article was originally published in The Gray Sheet
Executive Summary
Alphatec Spine aims to significantly expand its international sales presence and create the third-largest independent spinal device firm through its $116 million acquisition of French spinal implant company Scient'x